Literature DB >> 12668507

American Heart Association/American College of Cardiology Foundation guide to warfarin therapy.

Jack Hirsh, Valentin Fuster, Jack Ansell, Jonathan L Halperin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12668507     DOI： 10.1161/01.CIR.0000063575.17904.4E

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  100 in total

Review 1.  Paradoxical thrombosis, part 2: anticoagulant and antiplatelet therapy.

Authors:  Giuseppe Lippi; Emmanuel J Favaloro; Massimo Franchini
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

2.  Usefulness of international normalized ratio to predict bleeding complications in patients with end-stage liver disease who undergo cardiac catheterization.

Authors:  Jacob C Townsend; Richard Heard; Eric R Powers; Adrian Reuben
Journal:  Am J Cardiol       Date:  2012-06-22       Impact factor: 2.778

3.  Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939--an oral, direct Factor Xa inhibitor--after multiple dosing in healthy male subjects.

Authors:  Dagmar Kubitza; Michael Becka; Georg Wensing; Barbara Voith; Michael Zuehlsdorf
Journal:  Eur J Clin Pharmacol       Date:  2005-11-17       Impact factor: 2.953

4.  Utility of thrombophilia testing in patients with venous thrombo-embolism.

Authors:  Masataka Kudo; Huang L Lee; Ian A Yang; Philip J Masel
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

5.  Development of oral anticoagulants.

Authors:  Qing Ma
Journal:  Br J Clin Pharmacol       Date:  2007-05-15       Impact factor: 4.335

6.  Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients.

Authors:  Kevin E Chan; J Michael Lazarus; Ravi Thadhani; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2009-03-18       Impact factor: 10.121

7.  Analysis of CYP2C9 polymorphisms (*2 and *3) in warfarin therapy patients in Pakistan. Association of CYP2C9 polymorphisms (*2 and*3) with warfarin dose, age, PT and INR.

Authors:  Faiza Yasmeen; Muhammad Bilal Ghafoor; Abdul Wadood Khalid; Waqas Latif; Shahida Mohsin; Shagufta Khaliq
Journal:  J Thromb Thrombolysis       Date:  2015-08       Impact factor: 2.300

8.  Vegetables and Mixed Dishes Are Top Contributors to Phylloquinone Intake in US Adults: Data from the 2011-2012 NHANES.

Authors:  Stephanie G Harshman; Emily G Finnan; Kathryn J Barger; Regan L Bailey; David B Haytowitz; Cheryl H Gilhooly; Sarah L Booth
Journal:  J Nutr       Date:  2017-05-31       Impact factor: 4.798

9.  Patient time requirements for anticoagulation therapy with warfarin.

Authors:  Daniel E Jonas; Betsy Bryant Shilliday; W Russell Laundon; Michael Pignone
Journal:  Med Decis Making       Date:  2009-09-22       Impact factor: 2.583

Review 10.  The application of fuzzy logic to the prescription of antithrombotic agents in the elderly.

Authors:  Cathy M Helgason
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.